Occurrence rate of retinal detachment after small gauge vitrectomy for idiopathic epiretinal membrane
- PMID: 28524883
- PMCID: PMC5601454
- DOI: 10.1038/eye.2017.79
Occurrence rate of retinal detachment after small gauge vitrectomy for idiopathic epiretinal membrane
Abstract
PurposeTo assess the occurrence rate of retinal detachment (RD) after small gauge vitrectomy for idiopathic epiretinal membrane (ERM).Patients and methodsRetrospective observational case series. The records of consecutive patients operated on for idiopathic ERM using small gauge pars plana vitrectomy between August 2012 and December 2014 with at least a 1-year follow-up were reviewed. All patients were contacted by phone to assess the occurrence of RD during the post-operative follow-up. The main outcome was the occurrence of RD. Patients who underwent surgery for senile cataract over the same period with at least a 1-year follow-up were also contacted by phone for comparison.ResultsTwo hundred and sixteen eyes of 212 patients who had undergone ERM surgery were included, with a mean follow-up of 892±211 days (216-1238). RD occurred in two eyes (0.92%). Over the same period, two RD occurred in the 203 eyes (0.98%) of 157 patients operated on for senile cataract in our department.ConclusionsThe occurrence of RD after 25-gauge vitrectomy for idiopathic ERM was <1%. Using small gauge sutureless vitrectomy systems has improved the safety of ERM surgery, with a RD rate similar to that observed after cataract surgery.
Conflict of interest statement
EP: Novartis, Bayer, Allergan (travel expenses). RT: board membership (Alcon, Novartis, Allergan, Bausch&Lomb, Pfizer, Alimera, Bayer, FCI-Zeiss, Thrombogenics), consultancy (Alcon, Novartis, Allergan, Bausch&Lomb, Dorc, Takeda, FCI-zeiss, Thrombogenics). BD: consultancy (Novartis, Bayer), board membership (Novartis, Allergan). The remaining authors declare no conflict of interest.
Figures
References
-
- Fraser-Bell S, Guzowski M, Rochtchina E, Wang JJ, Mitchell P. Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study. Ophthalmology 2003; 110: 34–40. - PubMed
-
- Okamoto F, Okamoto Y, Hiraoka T, Oshika T. Effect of vitrectomy for epiretinal membrane on visual function and vision-related quality of life. Am J Ophthalmol 2009; 147(5): 869–874 874.e1. - PubMed
-
- Margherio RR, Cox MS, Trese MT, Murphy PL, Johnson J, Minor LA. Removal of epimacular membranes. Ophthalmology 1985; 92: 1075–1083. - PubMed
-
- Song SJ, Kuriyan AE, Smiddy WE. Results and prognostic factors for visual improvement after pars plana vitrectomy for idiopathic epiretinal membrane. Retina 2015; 35: 866–872. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
